Table 1 Demographic and clinical characterstics of the pnHIV and control groups

Demographic and Clinical Data*

Age (years)

29.1 [27.7, 31.6]

28.0 [25.0, 31.0]

Female Sex

10 (71.4%)

17 (65.4%)

Race

Black/African-American

12 (85.7%)

22 (84.6%)

White

2 (14.3%)

3 (11.5%)

Unknown

0 (0%)

1 (3.8%)

BMI (kg/m2)

30.5 [24.5, 35.7]

30.4 [23.7, 34.5]

BSA (m2)

1.8 [1.7, 2.0]

1.9 [1.7, 2.1]

Hypertension

1 (7.1%)

3 (11.5%)

Missing

0

0

Dyslipidemia

0 (0%)

1 (3.8%)

Missing

0

2

Diabetes Mellitus

1 (7.1%)

0 (0%)

Missing

0

1

Myocardial Infarction

0 (0%)

0 (0%)

Missing

0

1

NYHA Class

NYHA Class I

13 (92.9%)

--

NYHA Class II

1 (7.1%)

--

Laboratory Data

eGFR (mL/min)

114.1 [92.3, 124.7]

93.3 [87.4, 119.3]

Missing

1

3

CD4 count (cells/uL)

632.5 [562.5, 1171.2]

--

Viral load (copies/mL)

0.0 [0.0, 23.0]

--

Missing

3

--

LV Mass Index (g/m2)

63.3 [54.8, 79.5]

--

Missing

0

--

Relative Wall Thickness (cm)

0.4 [0.3, 0.4]

--

LVIDd (cm)

4.5 [4.3, 4.7]

--

Calculated EF (%)

58.0 [55.0, 60.0]

--

Missing (n)

1

--

E/A Ratio

1.5 [1.4, 1.6]

--

E/E’ Ratio

6.6 [6.0, 8.0]

--

Global Longitudinal Strain (%)

-18.1 [-19.2, -17.2]

--

CMR Data

T1 Pre-Contrast (milliseconds)

1230.1 [1220.1, 1242.9]

1235.4 [1210.4, 1256.0]

Missing

1

0

Extracellular Volume (%)

25.5 [24.1, 27.5]

27.5 [23.7, 28.8]

Missing

1

0

LV End-Diastolic Volume (mL)

139.7 [128.0, 147.0]

127.8 [114.1, 156.0]

Missing

1

0

LV End-Systolic Volume (mL)

58.8 [46.8, 60.8]

49.7 [43.1, 66.2]

Missing

1

0

LV Ejection Fraction (%)

58.4 [58.0, 63.8]

61.3 [58.4, 63.0]

Missing

1

0

LV Cardiac Output (Liters/minute)

5.6 [5.2, 6.0]

5.8 [5.2, 6.3]

Missing

1

0

LV Mass (grams)

96.5 [81.9, 104.7]

102.0 [82.5, 132.7]

Missing

1

0